Related Experiment Video
Updated: Jun 17, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Red blood cell transfusions in newborn infants: Revised guidelines
Insights
Healthcare providers are limiting red blood cell transfusions for high-risk newborns. Guidelines aim to reduce infant anemia, decrease transfusion needs, and minimize donor exposure in neonatal intensive care units.
Area of Science:
- Neonatal Medicine
- Pediatric Hematology
Background:
- Neonatal intensive care units (NICUs) have seen a trend towards more conservative red blood cell transfusion practices over the last decade.
- High-risk infants, including preterm and term newborns up to one month of age, are the focus of evolving transfusion guidelines.
Purpose of the Study:
- To establish guidelines for reducing anemia incidence in preterm and term infants.
- To identify effective strategies for decreasing the necessity of red blood cell transfusions.
- To minimize donor blood exposure in high-risk neonatal populations.
Main Methods:
- This is a guideline statement, not a research study.
- It synthesizes current practices and expert recommendations for managing anemia and transfusion in neonates.
- Recommendations for red blood cell transfusion are provided.
Main Results:
- The statement provides a framework for more restrictive red blood cell transfusion use.
- It outlines methods to prevent and manage anemia in high-risk newborns.
- Strategies focus on reducing transfusion frequency and donor exposure.
Conclusions:
- Adherence to these guidelines can optimize anemia management in high-risk infants.
- Reducing red blood cell transfusions minimizes risks associated with donor exposure.
- This approach supports evidence-based care in neonatal intensive care units.
Abstract:
In general, health care professionals taking care of high risk infants in neonatal intensive care units have become more restrictive in their use of red blood cell transfusion over the past 10 years. The present statement is intended for those caring for high risk newborn infants (preterm to one month of age). The objectives of this statement are to provide guidelines to reduce the incidence of anemia in preterm and term infants, to identify strategies to decrease the need for red blood cell transfusions and to limit donor exposure in this population. Recommendations for red blood cell transfusions are included.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Rh Blood Group
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion